Expression of cytochrome P-450(CYP)2B1/2 in lymphocytes of workers exposed to toluene and xylene

Toluene과 Xylene 노출 근로자의 림포사이트에서 Cytochrome P-450(CYP)2B1/2의 발현

  • Kim, Ki-Woong (Occupational Safety and Health Research Institute, KOSHA)
  • 김기웅 (한국산업안전보건공단 산업안전보건연구원)
  • Received : 2011.02.25
  • Accepted : 2011.03.17
  • Published : 2011.03.31

Abstract

In order to develop the methods for exposure assessment and find susceptibility markers for the workers who are exposed to low doses of toluene, xylene and other chemical in petroleum industries, we investigated the application of P-450 expression in human lymphocytes utilizing mouse monoclonal anti-rat CYP2B1/2, the levels of toluene and xylene in air and their metabolite levels in urine with the levels of expressed CYP2B1/2 proteins. The general characteristics such as age, smoking and drinking habit were no significant difference between the control and exposed workers, but the working durations and working hours were significantly different. Workers in exposed group were exposed to the mean of 2.1 ppm (range, 0.00-4.54) of toluene and 0.3 ppm (rang, 0.00-1.23) of xylene. The mean concentration of urinary hippuric acid was low and less than 1/5 of the biological exposure index recommended by the Ministry of Employment and Labor Korea. Methyl hippuric acid in urine was not detected in control and exposed workers. Also, there were no significant differences in the levels of the urinary metabolites between the control and exposed group. When chemiluminescence dot blottings were carried out utilizing mouse monoclonal antibody against CYP2B1/2, the strong density dots corresponding to a mouse monoclonal antibody was observed in the human lymphocytes from the exposed workers. These results suggested that the chemiluminescence dot blot assay for CYP of lymphocytes should be valuable for identifying CYP expression as biomarkers in the workers exposed to toluene and xylene.

Keywords

References

  1. 고용노동부. 산업안전보건법령집. 2009
  2. 김기웅, 허경화, 원용림, 정진욱, 김태균, 박인정. Styrene 노출에 반응을 보이는 혈청 단백질에 대한 프로테오믹스 분석. 한국산업위생학회지2007;17(3):235-244
  3. 김기웅, 허경화. Xylene에 의한 CYP2B1/2의 유도와 대사에 있어서 toluene의 영향. 한국산업위생학회지 2009;19(1):73-79
  4. 배기택, 문덕환, 김종한, 문찬석, 이채언. 톨루엔 크실렌 및 벤젠폭로의 생화학적지표들에 관한 연구. 대한산업의학회지 1991;3(2):165-176
  5. Arlien-S?borg P. Solvent neurotoxicity. CRC Press Inc., Florida, 1992, 107-124
  6. Carvalho D, Lanchote VL, Bonato PS, Queiroz R, Santos AC, and Dreossi S. A new derivatization procedure for the analysis of hippuric acid and methyl hippuric acid by gaschromatography. Int Arch Occup Environ Health 1991;63:33-37 https://doi.org/10.1007/BF00406195
  7. Chung W-G. Roh H-K, Kim H-M, Cha Y-N. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP1A2 and flavin-containing monooxygenase in N-demethylation of caffeine: identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns. Chemico-Biological Interactions 1998;113:1-14 https://doi.org/10.1016/S0009-2797(97)00109-9
  8. Cohr KH, Stokholm J. Toluene. a toxicology review. Scand J Work Environ Health 1979;5:71-90 https://doi.org/10.5271/sjweh.2664
  9. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutation Res 2004;567:447-474 https://doi.org/10.1016/j.mrrev.2004.02.001
  10. Elovaara E, Stockmann-Juvala H, Mikkola J, Gelboin HV. Interactive effects of methyl tertiary-butyl ether (MTBE) and tertiary-amyl methyl ether (TAME), ethanol and some drugs: Triglyceridemia, liver toxicity and induction of CYP (2E1, 2B1) and phase II enzymes in female Wistar rats. Environ Toxicol Pharmacol 2007;23:64-72 https://doi.org/10.1016/j.etap.2006.07.003
  11. Foy JW, Schatz RA. Inhibition of rat respiratory-tract cytochrome P- 450 activity after acute low-level m-xylene inhalation: role in 1-nitro-naphthalene toxicity. Inhal Toxicol 2004;16(3):125-132 https://doi.org/10.1080/08958370490270927
  12. Kataoka H, Saito K. Recent advances in SPME techniques in biomedical analysis. J Pharmaceutical and Biomedical Analysis 2011;54:926-950 https://doi.org/10.1016/j.jpba.2010.12.010
  13. Lauwerys RR, Hoet P. Industrial Chemical Exposure: Guidelines for Biological Monitoring. 2nd ed., Lewis Publishers, Florida, 1993, 1-13
  14. LoPachin RM, Jones RC, Patterson TA, Slikker WJr, Barber DS. Application of proteomics to the study of molecular mechanisms in neurotoxicology. Neurotoxicology 2003;24(6) :761-775 https://doi.org/10.1016/j.neuro.2003.08.003
  15. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radical Biology & Medicine 2008;44:723-738 https://doi.org/10.1016/j.freeradbiomed.2007.11.004
  16. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004;14(1):1-18
  17. NIOSH. NIOSH manual of analytical methods, 4th ed., Method 1051, U.S. Department of Health and Human Services, Cincinnati 1996
  18. Ogata M, Sugihara R, Kira S. Quantitative determination of urinary HA and m- or p-xylene exposure by HPLC. Int Arch Occup Environ Health 1977;39:199-206 https://doi.org/10.1007/BF00409366
  19. Omura T, Ishimura Y, Fujii-Kuriyama Y. Cytochrome P-450. 2nd ed., Kodansha Ltd, Tokyo, 1993
  20. Razavi M, Pope ME, Soste MV, Eyford BA, Jackson AM, Anderson NL, Pearson TW. MALDI immunoscreening (MiSCREEN): A method for selection of anti-peptide monoclonal antibodies for use in immunoproteomics. J Immunological Methods 2011;364:50-64 https://doi.org/10.1016/j.jim.2010.11.001
  21. Stierum R, Heijne W, Kienhuis A, Ommen BV, Groten J. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals. Toxicol Appl Pharmacol 2005;207:S179-S188